I agree that this site is using cookies. You can find further informations here.
X
Garelja, Michael L.
34  results:
Search for persons X
?
1

The processing intermediate of human amylin, pro-amylin(1–4..:

Mazzini, Giulia ; Le Foll, Christelle ; Boyle, Christina N....
Biophysical Chemistry.  308 (2024)  - p. 107201 , 2024
Link: https://doi.org/10.1016/..
 
?
2

Calcitonin receptor, calcitonin gene-related peptide and am..:

Rees, Tayla A. ; Tasma, Zoe ; Garelja, Michael L....
The Journal of Headache and Pain.  25 (2024)  1 - p. , 2024
Link: https://doi.org/10.1186/..
 
?
3

Calcitonin receptors in GtoPdb v.2023.1:

Walker, Christopher S. ; Poyner, David R. ; Hay, Debbie.
IUPHAR/BPS Guide to Pharmacology CITE.  2023 (2023)  1 - p. , 2023
Link: https://doi.org/10.2218/..
 
?
4

Pharmacological characterisation of erenumab, Aimovig, at t..:

Garelja, Michael L. ; Alexander, Tyla I. ; Bennie, Amy...
British Journal of Pharmacology.  181 (2023)  1 - p. 142-161 , 2023
Link: https://doi.org/10.1111/..
 
?
5

A narrative review of the calcitonin peptide family and ass..:

Garelja, Michael L. ; Hay, Debbie L.
Headache: The Journal of Head and Face Pain.  62 (2022)  9 - p. 1093-1104 , 2022
Link: https://doi.org/10.1111/..
 
?
6

Characterization of Antibodies against Receptor Activity-Mo..:

Hendrikse, Erica R. ; Rees, Tayla A. ; Tasma, Zoe...
International Journal of Molecular Sciences.  23 (2022)  24 - p. 16035 , 2022
Link: https://doi.org/10.3390/..
 
?
7

Pharmacological characterisation of mouse calcitonin and ca..:

Garelja, Michael L. ; Bower, Rebekah L. ; Brimble, Margaret A....
British Journal of Pharmacology.  179 (2021)  3 - p. 416-434 , 2021
Link: https://doi.org/10.1111/..
 
?
8

CGRP receptor antagonists for migraine. Are they also AMY1 ..:

Garelja, Michael L. ; Walker, Christopher S. ; Hay, Debbie L.
British Journal of Pharmacology.  179 (2021)  3 - p. 454-459 , 2021
Link: https://doi.org/10.1111/..
 
?
9

Molecular Mechanisms of Class B GPCR Activation: Insights f..:

Garelja, Michael L. ; Au, Maggie ; Brimble, Margaret A....
ACS Pharmacology & Translational Science.  3 (2020)  2 - p. 246-262 , 2020
Link: https://doi.org/10.1021/..
 
?
10

Pharmacological Characterization and Investigation of N-Ter..:

Musa, Hala ; Hendrikse, Erica R. ; Brimble, Margaret A....
Biochemistry.  58 (2019)  32 - p. 3468-3474 , 2019
Link: https://doi.org/10.1021/..
 
?
11

A potent fluorescent calcitonin gene‐related peptide analog..:

Yule, Lauren R. ; Garelja, Michael L. ; Hendrikse, Erica R....
Peptide Science.  111 (2019)  6 - p. , 2019
Link: https://doi.org/10.1002/..
 
?
12

Photoaffinity Cross-Linking and Unnatural Amino Acid Mutage..:

Simms, John ; Uddin, Romez ; Sakmar, Thomas P....
Biochemistry.  57 (2018)  32 - p. 4915-4922 , 2018
Link: https://doi.org/10.1021/..
 
?
13

Receptor Activity Modifying Proteins Have Limited Effects o..:

Garelja, Michael L. ; Walker, Christina A. ; Siow, Andrew...
Biochemistry.  57 (2018)  8 - p. 1410-1422 , 2018
Link: https://doi.org/10.1021/..
 
?
14

Update on the pharmacology of calcitonin/CGRP family of pep..:

Hay, Debbie L ; Garelja, Michael L ; Poyner, David R.
British Journal of Pharmacology.  175 (2017)  1 - p. 3-17 , 2017
Link: https://doi.org/10.1111/..
 
?
15

Receptor activity-modifying protein dependent and independe..:

Woolley, Michael J. ; Reynolds, Christopher A. ; Simms, John...
Biochemical Pharmacology.  142 (2017)  - p. 96-110 , 2017
Link: https://doi.org/10.1016/..
 
1-15